Background: We hypothesized that the factors which may in¯uence health status would dier in patients at dierent disease stages of chronic obstructive pulmonary disease (COPD). The present study investigated how impairments in health status were distributed in male patients at each disease stage according to the British Thoracic Society (BTS) guidelines, and analysed the contribution of the clinical indices, the dyspnoea rating and the psychological status to the health status of patients at the three disease stages of COPD.
Introduction
Patients with COPD can be functionally divided into three stages based on their severity of air¯ow limitation (1) . This standardized categorization can facilitate prognostication, clinical recommendations and health source planning in patients with COPD (1) . The percentage of the predicted FEV 1 is used as the basis for the staging systems proposed by the British Thoracic Society (BTS) (1), as well as by the American Thoracic Society (ATS) (2) and the European Respiratory Society (3) . Although the precise boundaries chosen are rather arbitrary and dier between each set of guidelines, the following severity ranges were established in the BTS guidelines: mild COPD with a FEV 1 at 60±79% of the predicted value, moderate COPD at 40±59% of the predicted value, and severe COPD at below 40% of the predicted value.
When evaluating patients with COPD, the health status or health-related quality of life has been recognized as one of the more important outcomes in clinical studies (4, 5) , and the BTS guidelines emphasized that improving the quality of life is one of their goals. The relationship between disease staging and health status warrants further investigation. For example, Ferrer et al. showed that the worse disease stage de®ned by the ATS presented with the worse health status (6) ; they also pointed out that patients at ATS stage I had a poorer health status than reference groups of healthy people. However, the relationship between the BTS guidelines and the health status has yet to be examined.
The major factors that in¯uence the health status of patients with COPD are dyspnoea and their psychological status, whereas physiological parameters such as their exercise capacity and FEV 1 generally do not contribute very much to impairments in health status (7) . However, it remains unclear whether the same factors aect patients with an early stage of COPD vs. severe disease stage. We hypothesized that the factors which may in¯uence the health status would dier in patients at the three dierent disease stages. In the present crosssectional study, we investigated how impairments in the health status were distributed in male COPD patients at each disease stage as de®ned by the BTS guidelines. We also evaluated correlations between their health status and other clinical variables, and analysed the contribution of pulmonary function, exercise capacity, the dyspnoea rating and the psychological status to the health status of COPD patients at the three disease stages. The health status was assessed with a disease-speci®c instrument, the St. George's Respiratory Questionnaire (SGRQ) (8) .
Methods

PATIENTS
Patients with stable COPD as de®ned by the BTS guidelines (1) were recruited from our outpatient clinic. All of the patients had at least 6 months of outpatient management before entry in order to avoid substantial changes in subjective parameters induced by any new medical interventions (9) . The entry criteria for this study were: (i) a maximal FEV 1 /vital capacity (VC) ratio of less than 0?7 and value of FEV 1 of less than 80% of the predicted for all measurements made over the prior 6 months; (ii) a smoking history of more than 20 pack-years; (iii) no history suggestive of asthma; (iv) no exacerbations of their air¯ow limitation over the preceding 6 weeks and (v) no changes in treatment regimen over the preceding 4 weeks. All eligible patients ®nished the following examinations on the same day, including pulmonary function testing, progressive cycle ergometer testing, an assessment of their health status and an assessment of their dyspnoea, anxiety and depression.
PULMONARY FUNCTION TESTS
FEV 1 and forced vital capacity (FVC) were assessed after the inhalation of bronchodilators was withheld for at least 12 h. All spirometric¯ow±volume curves were recorded according to the method described in the ATS 1994 update (10) . The predicted values for the FEV 1 and FVC were calculated based on the Japan Society of Chest Diseases' proposal (11) . The residual volume (RV) was measured by the closed-circuit helium method, and the transfer coecient for carbon monoxide (T LCO ) was measured using the single-breath technique (CHESTAC-65V, Chest, Tokyo, Japan). Patients on long-term domiciliary oxygen therapy (LTOT) were advised to stop inhaling their oxygen at least 12 h prior to their visits.
SYMPTOM-LIMITED PROGRESSIVE CYCLE ERGOMETER EXERCISE TEST
A progressive exercise test to a symptom-limited maximum was performed using an electrically braked cycle ergometer (Corival WLP-400, Lode, Groningen, The Netherlands) at 60 min after the inhalation of bronchodilators, as described by Ikeda et al. (12) . The workload was increased automatically, and the patients maintained a pedalling frequency above 40 cycles min 71 throughout the test. The exercise data were recorded with an automated exercise testing system (Desktop Diagnostics/CPX, Medical Graphic Corporation, St. Paul, U.S.A.). At the end of each exercise test, the maximal oxygen uptake ( VO 2 ) was calculated. All exercise tests were performed by the same researcher (M.T.), who did not have any prior knowledge of the results of the pulmonary function tests.
ASSESSMENT OF THE HEALTH STATUS, DYSPNOEA, ANXIETY AND DEPRESSION
Health status was assessed by the Japanese version of the SGRQ (8), which has previously been validated (7) . The SGRQ is divided into three components: symptoms (distress caused by speci®c respiratory symptoms), activity (physical activities that cause or are limited by breathlessness) and impacts (social and psychological eects of the disease). The total score for the SGRQ was also calculated following the procedures outlined by its developers. The SGRQ scores range from 0 to 100, with a zero score indicating no impairment in health status. Dyspnoea was evaluated with the Japanese version of the MRC dyspnoea scale, which consists of a ®ve-point grade (13) . The Japanese version of the Hospital Anxiety and Depression Scale (HADS) (14) was used to evaluate the patients' anxiety and depression status. The HADS consists of 14 items, seven of which score for anxiety and seven of which score for depression. It was scored in accordance with the methods proposed by it original author. The theoretical scores for anxiety and depression on the HADS range from 0 to 21; a score from 8 to 10 denotes borderline anxiety or depression and a score over 11 denotes clinical anxiety or depression. The SGRQ, MRC scale, and HADS were self-administered in booklet form. One of the authors (M.T.) checked all of the patients' answers in order to avoid possible missing items.
STATISTICAL ANALYSIS
All results are expressed as means +SD. The distribution of all variables approximated a normal distribution, and thus parametric tests were used throughout the present study. Relationships, between two sets of data were analysed using Pearson's product-moment correlation test. A P-value of less than 0?01 was considered to be statistically signi®cant. Dierences in the physiological values (RV/TLC, T LCO , and maximal VO 2 ) and the SGRQ scores among the subgroups were compared by an analysis of variance (ANOVA), and statistical signi®cance was established P50?05. Multiple pairwise comparisons were made with Fisher's least-signi®cant-dierence (LSD) method, with the overall a level set at 0?05. Forward and backward stepwise multiple regression analysis was performed to identify those variables which could predict the health status (15) . Variables that were judged to be important for COPD were used as independent variables for the regression analysis. The variables were the FEV 1 for air¯ow limitation, the RV/TLC ratio for hyperin¯ation, the T LCO % predicted for gas exchange, the VO 2 max for exercise capacity, the MRC scale for dyspnoea, and anxiety on the HADS for psychological status. The dependent variable for this statistical model was the total score from the SGRQ.
All analyses were performed with the statistical program Statview Version 4?1 (Abacus, Concepts, Berkeley, CA, U.S.A.).
Results
Patient characteristics are summarized in Table 1 . A total of 218 consecutive male patients with COPD were evaluated and were categorized into three stages of COPD based on the BTS guidelines. Twenty-®ve patients (11%) had mild COPD, 72 patients (33%) had moderate COPD, and 121 patients (56%) had severe COPD. Forty-six patients were current smokers. Two hundred and eleven patients (97%) were treated with inhalation of both b-agonists and anti-cholinergic agents. In addition to the inhaled agents, oral theophylline (300*800 mg day ±1 ) was administered in 22 patients (10%), and oral prednisolone (2?5*10 mg day 71 ) in 10 patients (5%). One hundred and four patients (48%) were also treated with high doses (1600*2400 mg day 71 ) of inhaled beclomethasone dipropionate. Five patients received no medication, and seven patients were managed with LTOT.
Signi®cant dierences were observed for the RV/TLC and the VO 2 max (one-way ANOVA, P50?05) The VO 2 max was signi®cantly lower in patients with severe COPD than in patients with moderate COPD (Fisher's LSD method, P50?05; indicated by { in Table 1 ). The VO 2 max was also signi®cantly lower for moderate COPD patients than for mild COPD patients (Fisher's LSD method, P50?05; indicated by * in Table 1 ). No signi®cant dierences in the T LCO were recognized among the three groups.
Signi®cant dierences were observed for the total score and for three components on the SGRQ (one-way ANOVA, P50?05), which are shown in Table 2 . The total score and the activity component on the SGRQ were signi®cantly higher in patients with severe COPD than in patients with moderate COPD (Fisher's LSD method, P50?05; indicated by { in Table 2 ), and were also signi®cantly higher for moderate COPD patients than for mild COPD patients (Fisher's LSD method, P50?05; indicated by * in Table 2 ). For the symptoms and impacts components of the SGRQ, the score in the severe COPD patients was signi®cantly higher than in mild COPD patients, but was not signi®cantly dierent from that in moderate COPD patients. No signi®cant dierences in the HADS scores were recognized among the three groups based on disease severity.
There were dierent patterns in the relationship between the SGRQ score and the other clinical variables among the The data represent mean (SD). T LCO : transfer factor for carbon monoxide; max: VO 2 maximal oxygen uptake. Mild COPD: FEV 1 60±79% of the predicted value; moderate COPD: FEV 1 40±59% of the predicted value; severe COPD: FEV 1 below 40% of the predicted value. *Signi®cant dierences in the values were observed for patients with mild COPD (Fisher's least-signi®cant-dierence method, P50?05). { Signi®cant dierences in the values of those with moderate COPD (Fisher's least-signi®cant-dierence method, P50?05). three disease stages (Table 3) . With respect to physiological parameters, FEV 1 had low correlation with the SGRQ score in patients with severe COPD [Pearson's correlation coecient (r)=70?24], but there were no signi®cant correlations in patients with mild or moderate COPD. The VO 2 max was signi®cantly correlated with the total SGRQ score in the mild COPD patients (r=70?67), but not in the moderate or severe patients. The MRC dyspnoea scale had strong correlations with the SGRQ score in all patient groups (r=0?53*0?70). Anxiety and depression on the HADS showed moderate correlations with the SGRQ score in the mild and severe COPD patients (r=0?51*0?57).
Results of the stepwise multiple regression analyses are shown in Table 4 . In patients with mild COPD, the MRC scale and VO 2 max accounted for 63% of the variance in the total score on the SGRQ. Anxiety on the HADS and the MRC scale accounted for 43% of the total SGRQ score in patients with moderate COPD. With respect to patients with severe COPD, Anxiety on the HADS, the MRC scale and the FEV 1 all signi®cantly in¯uenced the SGRQ.
Discussion
The present study showed that the disease staging proposed by the BTS guidelines could stratify male COPD patients For a de®nition of the abbreviations, see the footnotes of Tables 1 and 2 . Numbers in the square parentheses represent P-values.
according to varying degrees of impairment in their health status. We found that the health status of patients with mild to severe COPD had dierent patterns with respect to its correlations with physiological parameters, and that the factors that in¯uenced the impairments in the health status of COPD patients diered between the three disease stages. In terms of improving health status, it may be reasonable to change medical interventions and therapeutic goals in accordance with the disease stage.
To our knowledge, the present study is the ®rst report on the relationship between health status and disease staging proposed by the BTS guidelines. This study demonstrated that patients in the worst disease stage had the worst scores on the total SGRQ and on the activity component; the scores for the symptoms and impacts components also showed the same tendency. In this regard, the boundaries chosen for the BTS staging may be appropriate with respect to the health status. However, the precise boundaries chosen for the staging are rather arbitrary: the BTS guidelines selected 80%, 60% and 40% as the cut-o points for the predicted FEV 1 values (1), whereas the ATS guidelines are set at 80%, 50% and 35% (2). Ferrer et al. reported that patients in the worst disease stage de®ned by the ATS guidelines had the worst health status as evaluated by the SGRQ and a generic instrument, the Nottingham Health Pro®le (6) .
In patients with mild COPD, the exercise capacity as evaluated by the maximal oxygen consumption correlated signi®cantly with and in¯uenced the total score on the SGRQ; thus, their mildly decreased exercise capacity appeared to aect their health status. Our ®ndings support the recommendations of the BTS guidelines that patients with mild disease should be encouraged to continue with all of their usual activities.
Anxiety and dyspnoea played important roles in the health status of patients with moderate to severe COPD. Our results are consistent with the previous ®nding that anxiety was associated with an impaired health status (16) . The multiple regression analysis showed that anxiety in¯uenced the health status more in severe COPD patients than in moderate COPD patients, although there was no signi®cant dierence in the anxiety score on the HADS between these two groups. It is conceivable that anxiety and dyspnoea, both of which correlate with each other, may impact the health status strongly, especially in patients with severe COPD. In this regard, psychotherapy for patients with severe COPD may be considered as one of the therapeutic options. For example, in their pilot study, Eiser et al. demonstrated that cognitive and behavioural psychotherapy produced an improvement in exercise capacity (17) .
The present study con®rmed that dyspnoea is one of the main determinants of health status, and had moderateto-strong correlations with impairments in the health status of patients with mild-to-severe COPD, as previously reported (7, 18) . Since even mild breathlessness can impair the health status of patients with mild COPD, medical interventions for relieving dyspnoea such as inhaled bronchodilators may be justi®ed in the early stages of COPD.
We should mention the limitations of the present study. Our study included only males, since we experienced diculty in recruiting a sucient number of female patients with COPD. Therefore, any generalization of our results to women with COPD may be unwarranted. Second, since we recruited only stable patients from our outpatient clinic who were able to perform a progressive cycle ergometer test, some of the more symptomatic patients may have been excluded. We also experienced diculty in enrolling patients with mild COPD, mainly because they presented with very few symptoms and thus were reluctant to visit our clinic in a university setting. Since the cumulative coecients of determination in the regression analysis were not high, the indices used in this study may not be adequate, All of the values listed above represent a coecient of multiple determination (R 2 ). Numbers in the square parentheses represent standardized regression coecients. For a de®nition of the abbreviations, see the footnotes of Tables 1 and 2 .
Missing values indicate that the independent variables were not statistically signi®cant.
and unknown factors remain which may in¯uence the health status of patients with COPD.
In conclusion, the disease staging proposed by the BTS guidelines was able to stratify patients with COPD according to impairments in their health status. Furthermore, the factors that in¯uenced the health status diered in patients at the three dierent disease stages. Our ®ndings support the boundaries of the disease staging and some of the recommendations proposed by the BTS guidelines.
